Phillip Harrison

4.4k total citations · 1 hit paper
76 papers, 3.1k citations indexed

About

Phillip Harrison is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Phillip Harrison has authored 76 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hepatology, 34 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Phillip Harrison's work include Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (20 papers) and Hepatitis C virus research (17 papers). Phillip Harrison is often cited by papers focused on Liver Disease Diagnosis and Treatment (26 papers), Liver Disease and Transplantation (20 papers) and Hepatitis C virus research (17 papers). Phillip Harrison collaborates with scholars based in United Kingdom, United States and Germany. Phillip Harrison's co-authors include Julia Wendon, Sarah Hughes, Heiner Wedemeyer, Roger Williams, Graeme J.M. Alexander, Alexander Gimson, Richard Keays, Michael A. Heneghan, Farzin Farzaneh and John G. O’Grady and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Gastroenterology.

In The Last Decade

Phillip Harrison

76 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure

1991 407 citations Phillip Harrison, Julia Wendon et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phillip Harrison United Kingdom	28	2.1k	1.7k	749	430	345	76	3.1k
Charalambos G. Antoniades United Kingdom	22	1.4k 0.7×	1.0k 0.6×	477 0.6×	722 1.7×	540 1.6×	30	2.3k
Satoshi Mochida Japan	31	1.9k 1.0×	1.4k 0.8×	891 1.2×	402 0.9×	221 0.6×	144	3.0k
Ludger Leifeld Germany	26	824 0.4×	810 0.5×	477 0.6×	184 0.4×	528 1.5×	73	2.1k
Hitoshi Takagi Japan	32	1.5k 0.7×	1.3k 0.8×	963 1.3×	179 0.4×	198 0.6×	212	3.5k
Munther J. Hussain United Kingdom	25	1.3k 0.6×	1.2k 0.7×	528 0.7×	256 0.6×	642 1.9×	57	2.4k
Conrado Fernández‐Rodríguez Spain	25	1.5k 0.7×	1.5k 0.9×	476 0.6×	57 0.1×	125 0.4×	93	2.5k
Pier Maria Battezzati Italy	39	2.2k 1.1×	2.0k 1.2×	1.4k 1.9×	116 0.3×	271 0.8×	98	4.4k
E Pisi Italy	34	2.2k 1.1×	2.2k 1.3×	776 1.0×	108 0.3×	213 0.6×	125	3.8k
Nazia Selzner Canada	37	3.3k 1.6×	1.8k 1.0×	2.9k 3.9×	89 0.2×	374 1.1×	188	4.9k
Hirofumi Kawanaka Japan	32	1.6k 0.8×	1.2k 0.7×	1.6k 2.1×	60 0.1×	116 0.3×	176	3.1k

Countries citing papers authored by Phillip Harrison

Since Specialization

Citations

This map shows the geographic impact of Phillip Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Harrison more than expected).

Fields of papers citing papers by Phillip Harrison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Harrison. The network helps show where Phillip Harrison may publish in the future.

Co-authorship network of co-authors of Phillip Harrison

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Harrison. A scholar is included among the top collaborators of Phillip Harrison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Harrison. Phillip Harrison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harrison, Phillip, Antóin M. O’Sullivan, Stephen Peake, et al.. (2023). Reproductive ecology of muskellunge (Esox masquinongy), an introduced predator, in the lower Wolastoq/Saint John River, New Brunswick, Canada. Journal of Fish Biology. 102(3). 643–654. 1 indexed citations

Harrison, Phillip, Ashish Patel, Allen Cheng, & R. Bryan Bell. (2020). Three-Dimensional Computer-Assisted Surgical Planning, Manufacturing, and Intraoperative Navigation in Oncologic Surgery. Atlas of the Oral and Maxillofacial Surgery Clinics. 28(2). 129–144. 1 indexed citations

Makin, Erica, Phillip Harrison, Shailendra B. Patel, & Mark Davenport. (2012). Pancreatic Pseudocysts in Children. Journal of Pediatric Gastroenterology and Nutrition. 55(5). 556–558. 18 indexed citations

Bruce, Matthew, M. Horner, Deepak Joshi, et al.. (2012). Strong decline in HBsAg levels after virological response in a large monocentric therapy cohort: potential to select HBeAg positive chronic hepatitis B patients for finite duration?. Hepatology. 56. 2 indexed citations

Zuckerman, Mark, et al.. (2012). PMO-017 Perinatal hepatitis B in a high prevalence inner city population: direct electronic referral improves care. Gut. 61(Suppl 2). A79.2–A80. 3 indexed citations

Westbrook, Rachel, Sarah Hughes, John O’Grady, et al.. (2011). PREGNANCY IN CHOLESTATIC LIVER DISEASE. Hepatology. 54. 1 indexed citations

Sherwood, Roy, et al.. (2011). NO EFFECT OF TENOFOVIR OR ENTECAVIR ON VITAMIN D LEVELS IN CHRONIC HEPATITIS B MONO-INFECTED PATIENTS. SINGLE CENTRE 'REAL LIFE' COHORT EXPERIENCE. Hepatology. 54. 2 indexed citations

Carey, Ivana, et al.. (2011). DE-NOVO ANTIVIRAL THERAPY WITH NUCLEOS(T)IDE ANALOGUES IN 'REAL-LIFE' PATIENTS WITH CHRONIC HEPATITIS B INFECTION: COMPARISON OF VIROLOGICAL RESPONSES BETWEEN LAMIVUDINE plus ADEFOVIR VS. ENTECAVIR VS. TENOFOVIR THERAPY. Hepatology. 54. 8 indexed citations

Hughes, Sarah, Ivana Carey, Dazhuang Shang, et al.. (2009). HEPATITIS DELTA VIRUS RNA LEVEL AND IGM ANTIBODY TITER PREDICT RESPONSE TO PEG-INTERFERON THERAPY. Hepatology. 50(4). 2 indexed citations

10.

O’Beirne, James, Jon P. Mitchell, Farzin Farzaneh, & Phillip Harrison. (2009). Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells. Virology. 389(1-2). 1–7. 10 indexed citations

11.

Grammatikopoulos, Tassos, Mark Davenport, Phillip Harrison, et al.. (2008). 862 DOES AUTOIMMUNE PANCREATITIS EXIST IN CHILDHOOD? A TWENTY-YEAR SINGLE CENTRE RETROSPECTIVE REVIEW. Journal of Hepatology. 48. S323–S324. 1 indexed citations

12.

Cross, Timothy, Charalambos Antoniades, & Phillip Harrison. (2008). Non‐invasive markers for the prediction of fibrosis in chronic hepatitis C infection. Hepatology Research. 38(8). 762–769. 10 indexed citations

13.

Jensen, S L, Joanna P. Nicholls, Gordon Stamp, et al.. (2007). Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors. Cancer Immunology Immunotherapy. 56(12). 2003–2016. 47 indexed citations

14.

Orr, David, Phillip Harrison, John Devlin, et al.. (2006). Chronic Mesenteric Venous Thrombosis: Evaluation and Determinants of Survival During Long-Term Follow-up. Clinical Gastroenterology and Hepatology. 5(1). 80–86. 61 indexed citations

15.

Galea‐Lauri, Joanna, James W. Wells, David Darling, Phillip Harrison, & Farzin Farzaneh. (2004). Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell?based cancer vaccination. Cancer Immunology Immunotherapy. 53(11). 963–77. 64 indexed citations

16.

Galea‐Lauri, Joanna, David Darling, Ghulam Mufti, Phillip Harrison, & Farzin Farzaneh. (2002). Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunology Immunotherapy. 51(6). 299–310. 113 indexed citations

17.

Agarwal, Kosh, et al.. (2000). No association between primary sclerosing cholangitis (PSC) and CTLA-4 gene polymorphism: Evidence against an autoimmune aetiology?.. Hepatology. 32(4). 173. 3 indexed citations

18.

Harrison, Phillip. (1996). Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology. 23(5). 1067–1072. 62 indexed citations

19.

Wendon, Julia, Phillip Harrison, Richard Keays, et al.. (1991). Arterial-venous pH differences and tissue hypoxia in patients with fulminant hepatic failure. Critical Care Medicine. 19(11). 1362–1364. 15 indexed citations

20.

Basile, Anthony S., Robin D. Hughes, Phillip Harrison, et al.. (1991). Elevated Brain Concentrations of 1,4-Benzodiazepines in Fulminant Hepatic Failure. New England Journal of Medicine. 325(7). 473–478. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact